Indeed, suppression of TTP phosphorylation by MK2 inhibitor was shown to impair TTP activity in HCC cell lines [130], whereas TTP ability to regulate c-Myc was abrogated by methylation of a single CpG site in its promoter [131]. This evidence concerns the gene ZFP36 and hepatocellular carcinoma.